The Molecular Analysis for Precision Oncology Congress 2025 will take place from 15 to 16 September in Paris, France, uniting leading experts in oncology, molecular diagnostics, and precision medicine for dynamic discussions and collaboration, with a focus on decoding the molecular bases of cancer to enable precision oncology.

The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.

Attendees will explore the impact of artificial intelligence in revolutionising diagnostics, therapeutics, and outcomes, alongside advancements in cancer immunology and the next generation of immunotherapies.

Key themes will include aging and senescence, microbiome insights bridging basic research to clinical applications, and metabolism dysregulation, focusing on therapeutic vulnerabilities in cancer cells to foster innovative treatments.

Organised through a partnership between Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, MAP 2025 promises a cutting-edge programme at the forefront of cancer research and care.